Hematology Job at Indiana University Health in Indianapolis, IN

The Director of the Multiple Myeloma Program will be responsible for providing strategic direction & leadership for the program across IU Health's academic health system. The successful candidate will oversee clinical operations, ensure excellence in patient care, & drive research initiatives in multiple myeloma & related plasma cell disorders. This role presents an exceptional opportunity to build upon a robust clinical & research infrastructure, collaborating with faculty & university leaders to support our integrated academic, research, & clinical missions.

The selected candidate will lead a comprehensive research program in multiple myeloma, oversee clinical operations across multiple practice sites, contribute to the education & mentorship of the next generation of hematology-oncology specialists. Additionally, the candidate will provide specialized clinical care to patients with plasma cell disorders while advancing the scientific understanding of multiple myeloma through translational research initiatives.

Requirements
1. MD, DO, MD/PhD or equivalent degree with board certification in Hematology and Oncology, with demonstrated subspecialty expertise in multiple myeloma & plasma cell disorders
2. 5+ years of experience leading a clinical, translational, and/or basic research program focused on multiple myeloma, along with an independent, extramurally funded research program (e.g., NIH R01, industry-sponsored trials, or equivalent funding mechanisms)
3. Strong academic record with at least 5+ years of peer-reviewed publications in multiple myeloma or related hematologic malignancies, along with evidence of successful grant acquisition & research leadership

Responsibilities
Lead & manage the Multiple Myeloma Program across IU Health's academic medical centers, including University Hospital, IU North Hospital & the IU Simon Comprehensive Cancer Center
Collaborate closely with the Hematopoiesis & Hematological Malignancies (HHM) Research Program at IUSCCC to advance translational research initiatives
Work in partnership with the Brown Center for Immunotherapy at IU Melvin & Bren Simon Comprehensive Cancer Center to integrate novel cellular therapy approaches for multiple myeloma treatment
Develop & implement strategic initiatives to enhance patient outcomes, expand clinical trial opportunities, & establish the program as a regional and national referral center
Provide clinical oversight and academic guidance to faculty, fellows, residents, & advanced practice providers while mentoring junior faculty in research & clinical excellence
Expand the research portfolio with emphasis on investigator-initiated clinical trials, correlative studies, & translational research in multiple myeloma
Serve as a liaison with external partners, pharmaceutical industry, & stakeholders to develop collaborative research opportunities & enhance the program's national profile
Contribute to educational missions through teaching medical students, residents, & fellows in the principles of multiple myeloma management & research

Qualifications
MD or DO with BC in Hematology & Oncology
Subspecialty expertise & demonstrated clinical excellence in Multiple Myeloma & plasma cell disorders
Proven leadership experience in academic medicine with evidence of program development & management
Associate Professor or Full Professor, or qualifications commensurate with such appointment
Excellent communication, interpersonal, & collaborative skills

Academic Environment

Indiana University School of Medicine - Division of Hematology/Oncology
The faculty in the Hematology/Oncology Division are active in nationally and internationally recognized medical research and provide exceptional education programs and patient care. The division maintains a diverse group of faculty members, including 76 full/part-time faculty, 11 adjunct professors, 16 fellows, 18 postdoctoral fellows, and 25 advanced practice providers. Faculty provide comprehensive patient care at IU Health's downtown academic health center, the IU Simon Comprehensive Cancer Center, Sydney & Lois Eskenazi Health, and the Richard L. Roudebush Indianapolis VA Medical Center, as well as suburban facilities including IU Health West and IU Health Schwarz Cancer Center.

Our faculty maintain an exceptional track record of national leadership, including two American Society of Clinical Oncology (ASCO) presidents, one American Society of Hematology (ASH) president, four ASCO presidential candidates, and ten faculty who have served as chairs on various Eastern Cooperative Oncology Group (ECOG) committees.

Hematopoiesis and Hematological Malignancies (HHM) Research Program
The Multiple Myeloma Director will have opportunities to collaborate with the HHM Research Program at IUSCCC, which focuses on rigorous basic science and robust collaboration to advance the understanding and treatment of hematological malignancies. The program aims to elucidate cellular processes and intracellular signaling that drive the biology of multiple myeloma, understand the relationship between plasma cell disorders and the bone microenvironment, and determine mechanisms of treatment resistance.

Indianapolis, Indiana, the 17th largest U.S. city, is a sophisticated city blending charm and culture with a wonderful balance of business and leisure.Residents of this dynamic city enjoy:

• Leading educational system and top-ranked universities, paired with a diverse population
• Vibrant downtown offering arts, theaters, world-class museums, zoo, concerts and memorials
• Named to U.S. News & World Report's 2023-2024 list of the best places to live in the United States
• Top ranked international airport:"Best Airport in North America" twelve consecutive years
• Ranked by Niche in 2023 as one of the most diverse counties in America, as well as one of the best cities to live in and buy a house in the country
• Historic neighborhoods with surrounding cultural districts and low cost of living
• Outdoor recreation includes golfing, boating and unique parks
• Home of the Colts (NFL), Fever (WNBA), Pacers (NBA), Indians (MiLB), Indianapolis 500 (IndyCar) and the nation's largest half marathon
• Close proximity to Chicago, St. Louis, Louisville, and Cincinnati